Drug Resistance Patterns and Trends in Patients with Suspected Drug-Resistant Tuberculosis in Dalian, China: A Retrospective Study

References

• World Health Organization. Definitions and Reporting Framework for Tuberculosis – 2013 Revision. Geneva, Switzerland: World Health Organization; 2013.
   Google Scholar
• Wang MG, Wu SQ, He JQ. Efficacy of bedaquiline in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1). doi:10.1186/s12879-021-06666-8
   Web of Science ®Google Scholar
• Fox GJ, Nguyen TA, Coleman M, Trajman A, Velen K, Marais BJ. Implementing tuberculosis preventive treatment in high-prevalence settings. Int J Infect Dis. 2021;113:S13–S5. doi:10.1016/j.ijid.2021.02.094
   Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Report 2021. Geneva, Switzerland: World Health Organization; 2021.
   Google Scholar
• Zurcher K, Ballif M, Fenner L, et al. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study. Lancet Infectious Dis. 2019;19(3):298–307. doi:10.1016/S1473-3099(18)30673-X
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Report 2020. Geneva, Switzerland: World Health Organization; 2020.
   Google Scholar
• Ali S, Khan MT, Khan AS, Abbas Q, Irfan M. Fluoroquinolone Resistance Among Isolates of Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan. Microbial Drug Resistance. 2021;27(6):786–791. doi:10.1089/mdr.2020.0118
   Web of Science ®Google Scholar
• Alene KA, Xu ZH, Bai LQ, et al. Spatial clustering of drug-resistant tuberculosis in Hunan province, China: an ecological study. BMJ Open. 2021;11(4). doi:10.1136/bmjopen-2020-043685.
   Web of Science ®Google Scholar
• Song WM, Li YF, Ma XB, et al. Primary drug resistance of Mycobacterium tuberculosis in Shandong, China, 2004-2018. Respir Res. 2019;20(1). doi:10.1186/s12931-019-1199-3.
   Web of Science ®Google Scholar
• Tantan R, Puxuan L, Guofang D. 2020WHO tuberculosis report: key data for China, the whole world. Electronic J Em Infect Dis. 2020;5(4):280.
   Google Scholar
• Ding C, Wang ST, Shangguan YW, et al. Epidemic Trends of Tuberculosis in China from 1990 to 2017: evidence from the Global Burden of Disease Study. Infect Drug Resist. 2020;13:1663–1672. doi:10.2147/IDR.S249698
   Web of Science ®Google Scholar
• Tembo BP, Malangu NG. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana. BMC Infect Dis. 2019;19(1):1–8. doi:10.1186/s12879-019-4375-7
   PubMed Web of Science ®Google Scholar
• Günther G. Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges. Clin Med (Northfield Il). 2014;14(3):279. doi:10.7861/clinmedicine.14-3-279
   PubMed Web of Science ®Google Scholar
• Khan MT, Ali S, Khan AS, et al. Insight into the drug resistance whole genome of Mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa, Pakistan. Infect Genetics Evolution. 2021;92:104861. doi:10.1016/j.meegid.2021.104861
   Web of Science ®Google Scholar
• Du L, Zhang Y, Lv X, et al. Prevalence of multidrug-resistant tuberculosis in Dalian, China: a Retrospective Study. Infect Drug Resist. 2021;14:1037. doi:10.2147/IDR.S294611
   PubMed Web of Science ®Google Scholar
• Ji H, Xu J, Wu R, et al. Cut-off Points of Treatment Delay to Predict Poor Outcomes Among New Pulmonary Tuberculosis Cases in Dalian, China: a Cohort Study. Infect Drug Resist. 2021;14:5521. doi:10.2147/IDR.S346375
   Web of Science ®Google Scholar
• Rasool G, Khan AM, Mohy-Ud-Din R, Riaz M. Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert(®) MTB/RIF assay. Int J Immunopathol Pharmacol. 2019;33:2058738419827174. doi:10.1177/2058738419827174
   Web of Science ®Google Scholar
• Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Eng J Med. 2012;366(23):2161–2170. doi:10.1056/NEJMoa1108789
   PubMed Web of Science ®Google Scholar
• Wan L, Guo Q, Wei J-H, et al. Accuracy of a reverse dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China. Infect Dis Poverty. 2020;9(1):1–10. doi:10.1186/s40249-020-00652-z
   Web of Science ®Google Scholar
• Li X, Sheng L, Tu J, Lou L. A preliminary study on the synergistic effect of nano Ag and anti-tuberculosis drugs on drug-resistant Mycobacterium tuberculosis. J Nanosci Nanotechnol. 2020;20(10):6155–6160. doi:10.1166/jnn.2020.18597
   Web of Science ®Google Scholar
• Rahman SM, Ather MF, Nasrin R, et al. Performance of WHO-Endorsed Rapid Tests for Detection of Susceptibility to First-Line Drugs in Patients with Pulmonary Tuberculosis in Bangladesh. Diagnostics. 2022;12(2):410. doi:10.3390/diagnostics12020410
   Web of Science ®Google Scholar
• Definitions W. Reporting Framework for Tuberculosis–2013 Revision. Geneva: World Health Organization; 2013.
   Google Scholar
• Ullah I, Javaid A, Tahir Z, et al. Pattern of drug resistance and risk factors associated with development of drug resistant Mycobacterium tuberculosis in Pakistan. PLoS One. 2016;11(1):e0147529. doi:10.1371/journal.pone.0147529
   PubMed Web of Science ®Google Scholar
• Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar J-W. Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis. J Infection. 2018;77(6):469–478. doi:10.1016/j.jinf.2018.10.004
   Web of Science ®Google Scholar
• Desissa F, Workineh T, Beyene T. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. BMC Public Health. 2018;18(1):1–6. doi:10.1186/s12889-018-5371-3
   Web of Science ®Google Scholar
• Wang K, Chen SH, Wang XM, et al. Factors Contributing to the High Prevalence of Multidrug-Resistant Tuberculosis Among Previously Treated Patients: a Case-Control Study from China. Microbial Drug Resistance. 2014;20(4):294–300. doi:10.1089/mdr.2013.0145
   Web of Science ®Google Scholar
• Guidelines ATC. Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. J Assoc Physicians India. 2006;54:219–234.
   Google Scholar
• Jou R, Chiang C, Yu C, Wu M. Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan. Int j Tuberculosis Lung Dis. 2009;13(9):1142–1147.
   Web of Science ®Google Scholar
• Rajendran M, Zaki RA, Aghamohammadi N. Contributing risk factors towards the prevalence of multidrug-resistant tuberculosis in Malaysia: a systematic review. Tuberculosis. 2020;122:101925. doi:10.1016/j.tube.2020.101925
   Web of Science ®Google Scholar
• Baluku JB, Mukasa D, Bongomin F, et al. Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study. BMC Infect Dis. 2021;21(1):1–11. doi:10.1186/s12879-021-06801-5
   Web of Science ®Google Scholar
• Zhang C, Wang Y, Shi G, et al. Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study. BMC Public Health. 2015;16(1):1–8. doi:10.1186/s12889-016-2711-z
   Web of Science ®Google Scholar
• Suarez-Garcia I, Rodriguez-Blanco A, Vidal-Perez J, et al. Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur j Clin Microbiol Infect Dis. 2009;28(4):325–330. doi:10.1007/s10096-008-0627-y
   Web of Science ®Google Scholar
• Soeroto AY, Pratiwi C, Santoso P, Lestari BW. Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: a retrospective cohort study. PLoS One. 2021;16(2):e0246284. doi:10.1371/journal.pone.0246284
   Web of Science ®Google Scholar
• Ahmad AM, Akhtar S, Hasan R, Khan JA, Hussain SF, Rizvi N. Risk factors for multidrug-resistant tuberculosis in urban Pakistan: a multicenter case–control study. Int j Mycobacteriol. 2012;1(3):137–142. doi:10.1016/j.ijmyco.2012.07.007
   Google Scholar
• Hameed S, Ahmad SR, Rahman MAU, Nazir H, Ullah I. Drug resistance profile of Mycobacterium tuberculosis and predictors associated with the development of drug resistance. J Global Antimicrobial Resistance. 2019;18:155–159. doi:10.1016/j.jgar.2019.03.009
   Web of Science ®Google Scholar
• Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia. Int J Infect Dis. 2015;39:57–61. doi:10.1016/j.ijid.2015.08.013
   Web of Science ®Google Scholar
• Mehari K, Asmelash T, Hailekiros H, et al. Prevalence and factors associated with multidrug-resistant tuberculosis (MDR-TB) among presumptive MDR-TB patients in Tigray Region, Northern Ethiopia. Canadian J Infect Dis Med Microbiol. 2019;2019:548.
   Web of Science ®Google Scholar
• Workicho A, Kassahun W, Alemseged F. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study. Infect Drug Resist. 2017;10:91–96. doi:10.2147/IDR.S126274
   PubMed Web of Science ®Google Scholar
• Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC Infect Dis. 2015;15. doi:10.1186/s12879-015-1202-7
   Web of Science ®Google Scholar